← Back to Search

Assessment Tool for Cancer Care Planning

N/A
Waitlist Available
Led By Arti Hurria, MD
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying an assessment tool to help doctors plan treatment for older patients with cancer.

Who is the study for?
This trial is for older adults with any type of cancer who are about to start a new chemotherapy regimen. They must have confirmed cancer, understand English, and not be enrolled in another phase I clinical trial or this trial previously.
What is being tested?
The study is testing an assessment tool designed to evaluate cognitive functions and daily activity abilities in older cancer patients. This includes understanding how they think, learn, remember, make judgments during their treatment process.
What are the potential side effects?
Since the interventions involve assessments rather than medications (like cognitive tests and questionnaires), there aren't typical medication side effects; however, participants may experience stress or discomfort from discussing their condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Geriatric Assessment ToolExperimental Treatment3 Interventions
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
cognitive assessment
2005
Completed Phase 3
~1210
psychosocial assessment and care
2003
Completed Phase 4
~9920

Find a Location

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
602 Previous Clinical Trials
1,922,385 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,938 Previous Clinical Trials
41,022,108 Total Patients Enrolled
Arti Hurria, MDPrincipal InvestigatorCity of Hope Comprehensive Cancer Center
10 Previous Clinical Trials
1,257 Total Patients Enrolled
Dale William, MDPrincipal InvestigatorCity of Hope Medical Center

Media Library

psychosocial assessment and care Clinical Trial Eligibility Overview. Trial Name: NCT00477958 — N/A
Cancer-related distress Research Study Groups: Geriatric Assessment Tool
Cancer-related distress Clinical Trial 2023: psychosocial assessment and care Highlights & Side Effects. Trial Name: NCT00477958 — N/A
psychosocial assessment and care 2023 Treatment Timeline for Medical Study. Trial Name: NCT00477958 — N/A
~56 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top